ALOI, MARINA
ALOI, MARINA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study
2026 F. Scaldaferri, F. Di Vincenzo, M. Aloi, M. Ascolani, P. Balestrieri, L. Bertani, C. Bezzio, G. Bodini, F. Bossa, E. Calabrese, R. Cannatelli, F. Caprioli, M. Cappello, M. Cicala, F. D’Amico, S. Danese, A. De Bernardi, F.R. De Filippo, F. Desideri, D. Di Paolo, A. Di Sario, M.C. Fantini, C. Ferracane, S. Festa, G. Fiorino, R. Gabbiadini, A. Geccherle, V. Gerardi, E. Giangreco, A.G. Gravina, L. Laterza, L.R. Lopetuso, I. Marafini, M. Mastronardi, M. Mendolaro, M. Merli, G. Mocci, S. Onali, M.F. Onidi, L. Pastorelli, A. Piagnani, M.B. Principi, D. Pugliese, D.G. Ribaldone, A. Rispo, F. Rizzello, F. Santagata, E.V. Savarino, R. Spagnuolo, A. Tursi, A. Variola, C. Viganò, A. Armuzzi
Can liver biopsy be spared for the diagnosis of autoimmune hepatitis in selected children? A multicenter retrospective study
2026 V. Delle Cave, F. Di Dato, P.L. Calvo, M. Pinon, M. Aloi, F. Zucconi, R. Francavilla, E. Rizzitelli, F. Sbravati, P. Alvisi, R. Iorio
Exploring novel biomarkers in pediatric ulcerative colitis: The role of Lipocalin-2, MMP-9, and MMP-9/LCN-2 complex
2026 G. D'Arcangelo, R. Paparella, A. Gravina, F. Tarani, L. Tarani, M. Aloi, C. Petrella
Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study
2026 G. D'Arcangelo, D. Turner, O. Ledder, E. Orlanski‐meyer, E. Broide, M. Granot, M. Matar, S. Hussey, A. Yerushalmy‐feler, C. Norden, E. Miele, M. Aloi
Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in Children: A Multicenter Prospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Paediatric Gastroenterology Hepatology and Nutrition
2026 L. Scarallo, P. Alvisi, M. Bramuzzo, A. Domanico, J. Kierkus, M. Matar, C. Strisciuglio, J. De Laffolie, I. Broekaert, M. Aloi, M.V. Rodríguez-Belvís, S. Renzo, F. Labriola, L. Tasciotti, G. Dragoni, P. Lionetti
Impact of 5‐ASA discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study
2026 G. D'Arcangelo, L. Scarallo, G. Mancuso, M. Corpino, C. Romano, L. Norsa, S. Arrigo, M. Bramuzzo, M.T. Fioretti, G. Zuin, M.T. Illiceto, P. Lionetti, M. Aloi
Reshaping study design for faster extrapolation‐based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN–NASPGHAN position paper
2026 D. Turner, A. Assa, M. Malham, S.Y. Bar‐asher, C. Rayan, J.S. Hyams, H.H. Uhlig, B. Pasternak, D.C. Wilson, H.K. Michel, L. De Ridder, E. Zuckerman, M. Aloi, P. Szitanyi, M.C. Dubinsky, A.M. Griffiths, R. Saldana, J. Martín‐de‐carpi, E. Wine, R.K. Russell, J. Adler, J. Picoraro
Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn's disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
2026 E. Mortato, L.M. Rao, M. Aloi, A. Cioni, E. Matteini, A. Fico, S. Lambiase, R. Gaeta Shumak, L. Bianchi, E. Campione, L. Diluvio
Real-life durability and risk factors for biologic discontinuation in pediatric inflammatory bowel disease: results from the SIGENP IBD registry
2025 S. Lega, V. Dipasquale, G. D'Arcangelo, L. Scarallo, S. Ancona, F. Fedele, G. Zuin, F. Graziano, L. Norsa, S. Gatti, M.T. Illiceto, E. Felici, M. Corpino, P.M. Pavanello, R. Cozzali, P. Alvisi, A. Pizzol, C. Banzato, F. Penagini, A. Marseglia, S. Faraci, C. Luini, C. Strisciuglio, C. Moretti, M. Martinelli, S. Arrigo, P. Lionetti, M. Aloi, C. Romano, M. Giangreco, M. Bramuzzo
Management of pediatric inflammatory bowel diseases in limited-resource settings: A position paper from the Paediatric IBD Porto Group of ESPGHAN
2025 A.C. Hauer, M. Sultan, A. Darma, E. Altamimi, D.E. Serban, A. Assa, C.P.S. Franco, L. De Ridder, D.C. Wilson, N.A. Afzal, J. Bronsky, M. Georgieva, M. Aloi, V. Urbonas, V.M. Navas-López, J.R. Medina, D. Turner, J. Amil-Dias
Gene expression profile predicts response to antitumor necrosis factor in children with Crohn's disease: A Porto group biobank study, and a systematic review
2025 O. Atia, A. Azulay, G. Focht, O. Ledder, R. Lev-Tzion, T. Schwerd, K. Siebert, T. Faro, L. Chapuy, V. Groleau, K. Grzywacz, S. Amar, B. Moalem, R. Michailevitch, M. Bergel, L. Norsa, M. Aloi, M. Kubat, J. Bronsky, P.T. Walsh, S. Hussey, D. Ben-Zvi, D. Turner
Update on pediatric inflammatory bowel diseases epidemiology during SARS-CoV-2 outbreak:data from the Italian society of pediatric gastroenterology, epatology and nutrition registry
2025 P. Alvisi, M. Congiu, L. Scarallo, M. Aloi, C. Romano, D. Dilillo, D. Knafelz, G. Zuin, M. Bramuzzo, L. Norsa, M. Cananzi, M. Pastore, E. Felici, S. Arrigo, G. D'Arcangelo, G.L. Presti, M. Bacchini, V. Cipriani, P. Lionetti
Prevalence and trend of anemia in children with inflammatory bowel disease: A national register-based cohort study
2025 G. D'Arcangelo, M. Brecciaroli, G. Gagliostro, D. Auletta, S. Pellegrino, S. Arrigo, F. Graziano, E. Miele, M.T. Illiceto, P. Alvisi, D. Dilillo, C. De Giacomo, P. Lionetti, M. Pastore, M. Cananzi, M. Bramuzzo, R. Panceri, L. Norsa, M. Aloi
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study
2025 O. Atia, Z. Shavit-Brunschwig, R. Lev-Tzion, R. Stein, E. Broide, D. Urlep, J. Hyams, B. Weiss, M. Aloi, A. Assa, K. Gerasimidis, B. Nichols, R.K. Russell, D. Turner
The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn’s Disease
2025 G. D'Arcangelo, D. De Mitri, L. Busato, L. Bottino, F. Maccioni, A. Verrino, M. Aloi
Long‐term outcome of pediatric acute severe colitis: A prospective 5‐year follow‐up of the PRASCO trial
2025 D. Lachman, E. Orlanski‐meyer, R. Lev‐tzion, O. Ledder, A. Assa, Z. Shavit‐brunschwig, B. Yerushalmi, M. Aloi, A.M. Griffiths, L. Albenberg, I. Bar‐or, K. Kolho, D.S. Shouval, S. Cohen, D. Turner, O. Atia
Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group
2025 P.F. Van Rheenen, K. Kolho, R.K. Russell, M. Aloi, A. Deganello, S. Hussey, N. Junge, J. De Laffolie, M.R. Deneau, E. Fitzpatrick, A.M. Griffiths, I. Hojsak, E. Nicastro, A. Nita, M. Pakarinen, A. Ricciuto, L. De Ridder, A. Sonzogni, A. Tenca, M. Samyn, G. Indolfi
Is transmural healing better than mucosal healing in pediatric Crohn’s disease?
2025 G. D'Arcangelo, S. Rotulo, S. Oliva, G. Russo, M. Distante, F. Zucconi, L. Busato, C. Catalano, F. Maccioni, M. Aloi
Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization
2025 A. Assa, M. Aloi, S. Van Biervliet, J. Bronsky, J.M. Di Carpi, M. Gasparetto, L. Gianolio, H. Gordon, I. Hojsak, A.S. Hudson, S. Hussey, J. Van Limbergen, E. Miele, L. Norsa, O. Olén, G. Pellino, P. Van Rheenen, L. De Ridder, R.K. Russell, D.S. Shouval, E. Trindade, T. Dan, D.C. Wilson, A. Yerushalmy-Feler, E. Wine
Response to Letter to the Editor: “Prevalence and trend of anemia in children with inflammatory bowel disease”
2025 G. D'Arcangelo, M. Aloi, N. Null